Belgian Hematology Society Multiple Myeloma (BHS MM) Symposium is organized by Belgian Hematology Society (BHS) and would be held on Oct 20, 2017 at Hof Ter Musschen, Woluwe-Saint-Lambert, Brussel, Belgium. The target audience for this medical event for hematologists, hematology nurses, hematologists in training and other physicians interested.
Course Description:
The therapeutic landscape of multiple myeloma has dramatically changed over the
last years and is still in continuous evolution. Second-generation proteasome inhibitors,
new immunomodulatory drugs and monoclonal antibodies have improved the outcome
of myeloma patients and can be given in various combinations at different stages
of the disease.
Additional details will be posted as soon as they are available.